Previous Close | 17.33 |
Open | 17.32 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 17.09 - 17.69 |
52 Week Range | 11.16 - 35.95 |
Volume | |
Avg. Volume | 1,188,445 |
Market Cap | 811.833M |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | 13.13 |
EPS (TTM) | 1.34 |
Earnings Date | Oct 31, 2024 - Nov 04, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 24.25 |
Investors need to pay close attention to Pacira BioSciences (PCRX) stock based on the movements in the options market lately.
Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership ExperienceTAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the appointment of Shawn Cross as Chief Financial Officer. In this role, Mr. Cross will be responsible for overseeing all aspects of the company’s financial operations. “We are delighted to welcome